T

Traws Pharma Inc
D

TRAW

2.56000
USD
-0.04
(-1.54%)
مغلق
حجم التداول
560
الربح لكل سهم
-1
العائد الربحي
-
P/E
1
حجم السوق
20,456,620
المقالات

العنوان: Traws Pharma Inc

القطاع: Healthcare
الصناعة: Biotechnology
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.